1-12 of 12
Juan Besalduch, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Addition of Absolute Lymphocytes/Monocytes Ratio Improves the Revised-International Prognostic Index (R-IPI) in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Leyre Bento, MD, Antonia María Bautista-Gili, MD, Francesc García, Jordi Martínez-Serra, PhD, Lucía García-Mañó, MD, Marta García-Recio, MD, Carmen Ballester, MD, Jordi Ginés, MD, Paloma López, MD, Jaime Daumal, Rafael Ramos, MD, Antonio Salar, MD PhD, Antonia Sampol, MD PhD, Juan Besalduch, MD PhD, Antonio Gutiérrez, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2654.
https://doi.org/10.1182/blood.V126.23.2654.2654
Published: 2015
Journal Articles

Clinical Results of Gemox-R in Mantle CELL Lymphoma: The Role of Oxaliplatin

Marta García-Recio, MD, Antonio Gutierrez, MD PhD, Antonia Obrador-Hervia, PhD, Lucia García Mañó, MD, Leyre Bento, MD, Juan Besalduch, MD PhD, Jose Rodriguez, MD PhD, Antonia Sampol, Priam Villalonga, PhD, Silvia Fernandez, PhD
Journal: Blood
Blood (2015) 126 (23): 2722.
https://doi.org/10.1182/blood.V126.23.2722.2722
Published: 2015
Journal Articles

Differential Impact of Relative Dose-Intensity Reductions (DIR) in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP21 or R-CHOP14

Leyre Bento, MD, Francesc Garcia, PhD, Antonia Maria Bautista-Gili, Blanca Sanchez, Lucia Garcia, MD, Eva Gimeno, Jordi Martinez-serra, PhD, Mariana Ferraro, Raquel Del campo, Javier Vercher, Miguel Scaff, Ana Pacheco, Florencia Garcia, Rafael Ramos, MD, Carmen Ballester, Juan Besalduch, MD PhD, Joan Bargay, MD, Antonio Salar, MD, Antonio Gutierrez, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3073.
https://doi.org/10.1182/blood.V124.21.3073.3073
Published: 2014
Journal Articles

Persistent Benefit of VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Long-Term Follow-up of a Randomized Phase 3 Pethema/GEM Study

Laura Rosiñol, MD PhD, Albert Oriol, MD, Ana Isabel Teruel, MD, Dolores Hernandez, M Jesús Blanchard, Javier De La Rubia, Miquel Granell, MD, Juan Besalduch, MD PhD, Luis Palomera, Yolanda Gonzalez, M Asunción Echebeste, Joaquín Díaz-Mediavilla, Miguel T Hernandez, MD, Felipe de Arriba, Norma Carmen Gutierrez, PhD MD, M Luisa Martín-Ramos, M Teresa Cibeira, Maria Victoria Mateos, Joaquin Martinez-Lopez, MD PhD, Adrian Alegre, MD, Juan José Lahuerta, MD PhD, Jesus F. San Miguel, Joan Blade
Journal: Blood
Blood (2014) 124 (21): 3457.
https://doi.org/10.1182/blood.V124.21.3457.3457
Published: 2014
Journal Articles

Impact Of Dose-Density Delays In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-CHOP21 Or R-CHOP14

Antonio Gutierrez, MD, PhD, Antonia M Bautista-Gili, MD, Leyre Bento, MD, Ines Herraez, MD, Lucia Garcia, MD, Jordi Martinez-serra, PhD, Antonia Sampol, MD, PhD, Rafael Ramos, MD, Jordi Gines, MD, Carmen Ballester, MD, Albert Perez, MD, Paloma Lopez-Perezagua, MD, Jaime Daumal, MD, Jose Rodriguez, MD, PhD, Juan Besalduch, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4374.
https://doi.org/10.1182/blood.V122.21.4374.4374
Published: 2013
Journal Articles

The Impact Of European Leukemia Net (ELN) Genetic Classification On The Outcome Of Allogeneic Stem Cell Transplantation (ALLOHCT) For Acute Myeloid Leukemia (AML) In First Complete Remission

Jorge Sierra, PhD, MD, Ana Garrido, MD, Mar Tormo, MD, Ramon Guardia, MD, Josep F Nomdedeu, MD, Jordi Esteve, MD, PhD, Josep-Maria Ribera, MD, PhD, Rafael F. Duarte, MD, PhD, M. Paz Queipo De Llano, MD, Olga Salamero, MD, Carmen Pedro, MD, Joan Bargay, MD, Juan Besalduch, MD, PhD, Andreu Llorente, MD, Montserrat Hoyos, Montserrat Arnan, MD, Marta Pratcorona, MD, Susana Vives, MD, Marisa Calabuig, MD, David Gallardo, MD, PhD, Salut Brunet, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2107.
https://doi.org/10.1182/blood.V122.21.2107.2107
Published: 2013
Journal Articles

Radiotherapy Overcomes Adverse Prognostic Role Of COX-2 Expression On Reed-Sternberg Cells In Early Hodgkin Lymphoma

Antonio Gutierrez, MD, PhD, Mestre Francesc, MD, Jose Rodriguez, MD, PhD, Jordi Martinez-serra, PhD, Rafael Ramos, MD, Ines Herraez, MD, Antonia M Bautista-Gili, MD, Leyre Bento, MD, Lucia Garcia, MD, Jordi Gines, MD, Teresa Ros, Albert Perez, MD, Paloma Lopez-Perezagua, MD, Jaime Daumal, MD, Juan Besalduch, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1757.
https://doi.org/10.1182/blood.V122.21.1757.1757
Published: 2013
Journal Articles

Maintenance Therapy After Stem-Cell Transplantation for Multiple Myeloma with Bortezomib/Thalidomide Vs. Thalidomide Vs. alfa2b-Interferon: Final Results of a Phase III Pethema/GEM Randomized Trial

Laura Rosiñnol, MD, Albert Oriol, Ana Isabel Teruel, Dolores Hernández, Javier Lopez-Jimenez, MD, Javier De La Rubia, MD, Miquel Granell, MD, Juan Besalduch, MD, PhD, Luis Palomera, MD, Yolanda González, MD, Maria Asunción Etxebeste, Joaquín Díaz-Mediavilla, Miguel Teodoro Hernández, Felipe de Arriba, Adrian Alegre, María Teresa Cibeira, Maria Victoria Mateos, MD, PhD, Joaquin Martinez, MD, Juan José Lahuerta, Jesús F San Miguel, Joan Bladé, MD
Journal: Blood
Blood (2012) 120 (21): 334.
https://doi.org/10.1182/blood.V120.21.334.334
Published: 2012
Journal Articles

Gemcitabine and Oxaliplatinum (GemOx): An Effective Regimen in Patients with Refractory and Relapsing Hodgkin Lymphoma

Antonio Gutierrez, MD, PhD, Jose Rodriguez, Andres Lopez, Jordi Martinez-serra, Jorge Gines, María Pilar Paredes, Florencia Garcia, Javier Vercher, Josep Balanzat, Raquel Del campo, Pilar Galan, Miguel Morey, Joan Bargay, Juan Besalduch, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4845.
https://doi.org/10.1182/blood.V120.21.4845.4845
Published: 2012
Journal Articles

A Phase III PETHEMA/GEM Randomized Trial of Postransplant (ASCT) Maintenance in Multiple Myeloma: Superiority of Bortezomib/Thalidomide Compared with Thalidomide and Alfa-2b Interferon,

Laura Rosiñol, MD, María Teresa Cibeira, Maria Victoria Mateos, Joaquin Martinez, MD, Albert Oriol, Ana Isabel Teruel, Dolores Hernández, Javier López, MD, Javier de la Rubia, Miquel Granell, MD, Juan Besalduch, MD, PhD, Luis Palomera, Yolanda González, MD, Maria Asunción Etxebeste, MD, Joaquín Díaz-Mediavilla, Miguel T Hernández, MD, Felipe de Arriba, Adrian Alegre, Juan José Lahuerta, Jesus F San Miguel, MD PhD, Joan Blade
Journal: Blood
Blood (2011) 118 (21): 3962.
https://doi.org/10.1182/blood.V118.21.3962.3962
Published: 2011
Journal Articles

Effect of Pre and Post-Transplantation Responses on Outcome of Multiple Myeloma Patients: CR and near-CR Should Not Be Considered as Equivalent Prognostic Markers. Results of a PETHEMA/Gem Prospective Study

Juan José Lahuerta, Maria Victoria Mateos, Joaquin Martínez-López, Laura Rosinol, Anna Sureda, Javier de la Rubia, José García-Laraña, Rafael Martínez-Martínez, Miguel-Teodoro Hernández-García, Dolores Carrera, Juan Besalduch, MD, PhD, Felipe de Arriba, Jose-Maria Ribera, Lourdes Escoda, María-Belen Hernández-Ruiz, Javier García-Frade, Concepción Rivas-González, Adrian Alegre, Joan Blade, J.F. San Miguel
Journal: Blood
Blood (2008) 112 (11): 161.
https://doi.org/10.1182/blood.V112.11.161.161
Published: 2008
Journal Articles

Therapeutic Angiogenesis in Critical Limb Ischemia by Implantation of Autologous Hematopoietic Cells.

Juan Besalduch, MD, PhD, Raul Lara, MD, Antonia Sampol, MD, Antonio Gutierrez, MD, Pacual Lozano, MD, Antonio Galmes, MD; PhD
Journal: Blood
Blood (2005) 106 (11): 4222.
https://doi.org/10.1182/blood.V106.11.4222.4222
Published: 2005